Annual report [Section 13 and 15(d), not S-K Item 405]

Note 6 - Income Taxes

v3.26.3
Note 6 - Income Taxes
12 Months Ended
Sep. 30, 2026
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

Note 6. Income Taxes

 

For the fiscal years ended September 30, 2026, 2025, and 2024, the Company’s income (loss) from continuing operations before income taxes was $3,355,000, $8,667,000, and $(11,762,000), respectively, all of which was domestic. Income tax expense (benefit) from continuing operations consists entirely of U.S. federal and state income taxes. The Company had no foreign operations and, accordingly, no foreign income tax expense (benefit). Components of income tax expense (benefit) from continuing operations were as follows for the years ended:

 

   

September 30,

   

September 30,

   

September 30,

 

(In thousands)

 

2026

   

2025

   

2024

 

Current:

                       

Federal

  $ -     $ -     $ 385  

State

    52       80       (114 )

Current income tax expense

    52       80       271  

Deferred:

                       

Federal

    1,169       1,710       (3,092 )

State

    12       567       (427 )

Deferred income tax expense (benefit)

    1,181       2,277       (3,519 )

Income tax expense (benefit)

  $ 1,233     $ 2,357     $ (3,248 )

 

The following is a reconciliation of the federal statutory tax rate to the effective tax rate by amount and as a percent of income from continuing operations before income taxes for the year ended:

 

   

September 30, 2026

 

(Dollars in thousands)

 

Amount

    Percent  

U.S. federal statutory rate

  $ 705       21.0 %

State and local taxes, net of federal taxes (1)

    47       1.4 %

Tax credits

               

Research and development credits

    (63 )     (1.9% )

Nontaxable or nondeductible items

               

Meals and entertainment

    155       4.6 %

Excess tax benefits from stock-based compensation

    80       2.4 %

Section 162(m) limitation on officer’s compensation

    74       2.2 %

Other

    34       1.0 %

Changes in valuation allowances

    47       1.4 %

Other adjustments

               

Deferred tax rate change

    177       5.3 %

Other

    (23 )     (0.6% )

Effective tax rate

  $ 1,233       36.8 %

 

 

(1)

State taxes in Minnesota, North Carolina, Pennsylvania, and Texas made up a majority (greater than 50 percent) of the tax effect in this category.

 

The following is a reconciliation of the federal statutory tax rate to the effective tax rate as a percent of income (loss) from continuing operations before income taxes for the years ended:

 

   

September 30,

   

September 30,

 
   

2025

   

2024

 

U.S. federal statutory rate

    21.0 %     21.0 %

State and local taxes, net of federal taxes

    2.6 %     6.6 %

Permanent differences

    1.3 %     0.0 %

Research and development credits

    0.6 %     1.1 %

Section 162(m) limitation on officer’s compensation

    2.7 %     0.0 %

Excess tax benefits from stock-based compensation

    (1.1% )     (1.1% )

Effective tax rate

    27.2 %     27.6 %

 

As of September 30, 2026, the current U.S. income tax receivable was approximately $48,000. This amount is included in prepaid and other current assets in the Company’s consolidated balance sheet.

 

As of September 30, 2026 and 2025, the Company had a gross U.S. federal net operating loss (“NOL”) carryforward of $18,529,000 and $681,000, respectively. The federal NOLs do not expire and can be carried forward indefinitely. As of September 30, 2026 and 2025, the Company had a gross state NOL of $13,805,000 and $3,700,000, respectively. The state NOLs expire at varying amounts starting in 2040. As of September 30, 2026, the Company recorded a valuation allowance of $51,000 against deferred tax assets related to state NOLs in certain states where it is not more likely than not that they will be realized. The Company believes it is more likely than not that the remaining deferred tax assets related to U.S. federal and state NOLs will be realized, and therefore, a valuation allowance on these remaining deferred tax assets has not been recorded. As of September 30, 2025, no valuation allowance was recorded because the Company determined it was more likely than not that its deferred tax assets would be realized. In addition, as of September 30, 2026, and 2025, the Company had Minnesota research and development tax credits of $387,000 and $360,000, respectively. The Company had federal research and development tax credits of $124,000 and $106,000 as of September 30, 2026 and 2025, respectively. The Company has not recorded a valuation allowance on these research and development related deferred tax assets as the Company believes it is more likely than not they will be utilized before they begin to expire in fiscal year 2037.

 

Income tax payments by jurisdiction, net of refunds, were as follows for the year ended:

 

   

September 30,

 

(In thousands)

 

2026

 

Federal

  $ (1,456 )

State

    (7 )

Total income taxes (refunded) paid

  $ (1,463 )

 

Significant components of deferred income tax assets and liabilities were as follows for the years ended:

 

   

September 30,

   

September 30,

 

(In thousands)

 

2026

   

2025

 

Inventories

  $ 3,444     $ 3,521  

R&D expenses

    1,002       1,558  

Stock-based compensation

    1,269       1,223  

Investment in foreign subsidiary

    -       4,802  

Accrued expenses and reserves

    444       582  

Property and equipment depreciation

    663       654  

Net operating loss carry forwards and credits

    5,043       804  

Other

    190       -  

Total deferred tax asset

  $ 12,055     $ 13,144  

Goodwill

    (871 )     (906 )

Prepaid expenses

    (359 )     (284 )

Intangibles

    (1,150 )     (1,332 )

Foreign currency translation gain

    -       (359 )

Total deferred tax liability

  $ (2,380 )   $ (2,881 )

Valuation allowance

    (51 )     -  

Net deferred tax asset

  $ 9,624     $ 10,263  

 

Realization of NOL carryforwards and other deferred tax temporary differences are contingent upon future taxable earnings. The Company’s deferred tax assets were reviewed for expected utilization by assessing the available positive and negative factors surrounding their recoverability.

 

The Company is required to recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company applies the interpretation to all tax positions for which the statute of limitations remained open. The Company had no liability for unrecognized tax benefits and did not recognize any interest or penalties during the years ended September 30, 2026, or 2025.

 

The Company is subject to income taxes in the U.S. federal and various state jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. Clearfield, Inc. is generally subject to U.S. federal and state examination for all tax years after 2021.